CF4FRI

MACAPAGAL
PATIENT WAS INITIATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE MAY 13, 2016. SHE IS
ADVISED THRICE A WEEK HEMODIALYSIS, BUT IS COMPLIANT ONLY TO TWICE A WEEK TREATMENT.
NEVER HAS SHE BEEN COMPLIANT TO FLUID RESTRICTION AND COMES IN VOLUME OVERLOADED. SHE
CAME IN FOR HER REGULAR DIALYSIS TREATMENT.
(+) DM TYPE 2 WITH RETINOPATHY AND NEPHROPATHY
(+) ISCHEMIC CARDIOMYOPATHY
(+) S/POST NSTEMI
STANDING HEMODIALYSIS ORDERS:
DURATION: 4 HOURS
DIALYZER: HIGH FLUX (FDH 180)
ANTICOAGULATION: LMWHEPARIN 0.3
BLOOD FLOW RATE: 300CC/ML
DIALYSATE FLOW RATE: 700CC/MIN
UF GOAL: TO TARGET DRY WEIGHT OF 86 KG
THE PATIENT DISCHARGED STABLE AND WITH CONSTANT REMINDER OF STRICT ORAL RESTRICTION TO
LIMIT WEIGHT GAIN.
DELOS SANTOS
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE FEBRUARY 22, 2016. HE
IS CURRENTLY MAINATAINED ON TWICE A WEEK DIALYSIS AND CAME IN FOR HIS REGULAR TREATMENT.
JANUARY 30, 2014 - CMC; ESRD INITIATED ON HD
(+) HASCVD
(+) ARTHRITIS
DURATION: 4 HOURS
ANTICOAGULATION: UNFRACTIONATED HEPARIN (2ML INITIAL BOLUS, 1ML HOURLY)
BLOOD FLOW RATE: 300 CC/ML
DIALYSATE FLOW RATE: 600 CC/MIN
UF GOAL: TO TARGET DRY WEIGHT BUT NOT TO EXCEED UFR >750CC/HR
NO REPORTABLE INCIDENTS OR COMPLICATIONS OCCURRED DURING THE PROCEDURE.
PATIENT WAS DISCHARGED STABLE.
BAYANI
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE NOVEMBER 5, 2016. HE
IS CURRENTLY MAINTAINED ON THRICE A WEEK HEMODIALYSIS BUT MOST OFTEN ONLY COMPLY WITH
TWICE PER WEEK.
HE CAME IN FOR HIS REGULAR TREATMENT.
AUGUST 6, 2015 – CMC ESRD SEC TO CHRONIC GLO,ERULONEPHRITIS, INITIATED ON HD
(+) HASCVD
(+) ISCHEMIC CARDIOMYOPATHY WITH RHYTHM DISTURBANCE
(+) DM TYPE 2
(+) COPD BRONCHITIS
DURATION: 5 HOURS
ANTICOAGULATION: LMWH (TINZAPARIN 0.2 ML)

UF GOAL: TO TARGET DRY WEIGHT 65.5 KG
THE PATIENT IS SUBJECTED TO EXTENDED DIALYSIS TREATMENT SINCE HE CANNOT COMPLY TO MORE
FREQUENT HD TO ATTAIN HIS UF TARGETS THAT HIS DECOMPENSATED CARDIAC STATUS COULD
TOLERATE.
PATIENT WAS DISCHARGED STABLE AND WAS ADVISED STRICT ORAL FLUID RESTRICTION TO LIMIT
VOLUME OVERLOAD.
YAP
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE FEBRUARY 27, 2017. HE
IS CURRENTLY MAINTAINED ON THRICE A WEEK HEMODIALYSIS AND CAME IN FOR HIS REGULAR
TREATMENT.
(+) DM TYPE 2 W/ NEPHROPATHY AND RETINOPATHY
(+) ISCHEMIC CARDIOMYOPATHY/CHF
(+) PTB
S/P BKA BILATERAL
DURATION: 4 HOURS
ANTICOAGULATION:LMWH (TINZAPARIN 0.15 ML)
BLOOD FLOW RATE: 250 CC/ML
DIALYSATE FLOW RATE: 400 CC/MIN

UF GOAL: TO TARGET DRY WEIGHT 44.5 KGBUT NOT TO EXCEED UFR >750CC/HR
ALURA
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE JUNE 17, 2017. HE IS
CURRENTLY ON TWICE A WEEK DIALYSIS AND CAME IN FOR HER REGULAR TREATMENT.
(+) HYPERTENSION
(+) CAD
(+) BRONCHIAL ASTHMA
DURATION: 4 HOURS
ANTICOAGULATION: UNFRACTIONATED HEPARIN ( 1.5ML INITIAL BOLUS:0.5 ML HOURLY)
THE PATIENT HAD 1 EPISODE OF CRAMPS AND WAS RELIEVED UPON FLUSHING OF 100CC PNSS.
THE PATIENT HAD EPISODES OF BP ELEVATION DURING THE PROCEDURE AND WAS GIVEN HER
MAINTENANCE ANTIHYPERTENSIVES.
SHE WAS DISCHARGED STABLE
CASUPANG
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE JUNE 16, 2017. HE IS
CURRENTLY MAINATAINED ON TWICE A WEEK DIALYSIS AND CAME IN FOR HIS REGULAR TREATMENT.
(+) URATE/NSAID NEPHROPATHY WITH OCCASIONAL GOUTY ATTACKS
(+) HYPERTENSION
(+) AVF FAILURE, 2018
DURATION: 4 HOURS
ANTICOAGULATION: UNFRACTIONATED HEPARIN (2ML INITIAL BOLUS, 0.5- 1ML HOURLY)
UF GOAL: TO TARGET DRY WEIGHT 57 KG
TOLEDO
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE MAY 12, 2016. SHE IS
CURRENTLY MAINTAINE ON TWICE A WEEK HEMODIALYSIS AND CAME IN FOR HER REGULAR
TREATMENT.
JUNE 28, 2013 – CMC ESRD SEC TO DIABETIC KIDNEY DISEASE
(+) HPN
DURATION: 4 HOURS

MINA
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE OCTOBER 7, 2016. HE IS
CURRENTLY TWICE A WEEK DIALYSIS AND CAME IN FOR HER REGULAR TREATMENT.
JUNE 2014 – CMC ESRD SEC TO URATE/NSAID NEPHROPATHY, INITIATED ON HD STILL WITH GOUTY
FLARES
(+) ASCVD WITH RHYTHM DISTURBANCE (PACS/PVDS)
(+) DM TYPE 2
DURATION: 4 HOURS
UF GOAL: TO TARGET DRY WEIGHT OF 82.5 KG BUT NOT EXCEEDING 3.5L/HD SESSION
MAGADIA
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE MAY 16, 2017. HE IS
ESRD SECONDARY TO CHRONIC GLOMERULONEPHRITIS
HYPERTENSION, CONTROLLED
DURATION: 4 HOURS
ANTICOAGULATION: : UNFRACTIONATED HEPARIN (3ML INITIAL BOLUS- 1 ML HOURLY)
UF GOAL: TO TARGET DRY WEIGHT OF 72.5 KG
HOWEVER, PATIENT WAS NOTED TO HAVE DECREASE APPETITE & PROGRESSIVE WEIGHT LOSS DUE TO
PSYCHO-SOCIAL STRESSORS OTHER THAN THAT THE PATIENT WAS DISCHARGED STABLE.
LOPEZ
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE MAY 24, 2018. SHE IS
CURRENTLY MAINTAINED ON TWICE A WEEK HEMODIALYSIS AND CAME IN FOR HER REGULAR
TREATMENT.
(+) HCVD
(+) URATE/NSAID NEPHROPATHY WITH BOUTS OF GOUTY ARTHRITIS
S/P TAH AT 45 YEARS OLD SECONDARY TO MYOMA
DURATION: 4 HOURS

DEL ROSARIO
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE FEBRUARY 13, 2016. SHE
IS CURRENTLY MAINTAINED ON TWICE A WEEK HEMODIALYSIS AND CAME IN FOR HER REGULAR
TREATMENT.
JANUARY 2016- ESRD, HEMODIALYSIS INITIATION CAVITE MEDICAL CENTER
(+) HCVD
(+) DM TYPE 2
(+) DYSLIPIDEMIA
(+) AVF FAILURE LEFT, 2018
(+) PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
DURATION: 4 HOURS
ANDRADA
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE SEPTEMBER 16, 2016.
SHE IS CURRENTLY MAINTAINED ON TWICE A WEEK HEMODIALYSIS AND CAME IN FOR HER REGULAR
TREATMENT.
JANUARY 2016- ESRD, HEMODIALYSIS INITIATION CAVITE MEDICAL CENTER

(+) HCVD
(+) DM TYPE 2
(+) S/P AVG TAKE DOWN SECONDARY TO STEAL SYNDROME
(+) PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
DURATION: 4 HOURS
ANTICOAGULATION: LMWH (TINZAPARIN 0.15ML) WITH FLUSHING PNSS 50 CC EVERY 15 MINUTES
UF GOAL: TO TARGET DRY WEIGHT 55 KG BUT NOT EXCEEDING 2.5 L UF GOAL WITH FLUSHING
ESPINOSA
PATIENT HAD PROGRESSIVE AZOTEMIA AND PALLOR SINCE 2017 BUT WAS LOST TO FOLLOW-UP, UNTIL
AUGUST 2018 SHE HAD FULL LOWN UREMIC SIGNS AND SYMPTOMS, HENCE WAS INITIATED ON
HEMODIALYSIS. SHE IS CURRENTLY MAINTAINED ON TWICE A WEEK HEMODIALYSIS AND CAME IN FOR
HER REGULAR TREATMENT.
MARCH 18-21 2019- BAUTISTA HOSPITAL ; METABOLIC/UREMIC ENCEPHALOPATHY, CAP-MR
(+) HACVD
(+) DM TYPE 2
(+) PTB
DURATION: 4 HOURS
ANTICOAGULATION: UNFRACTIONATED HEPARIN (2 ML INITIAL BOLUS, 1 ML HOURLY)

SALGADO
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE FEBRUARY 27, 2017. SHE
IS CURRENTLY MAINTAINED ON TWICE A WEEK HEMODIALYSIS AND CAME IN FOR HER REGULAR
TREATMENT.
(+) HACVD
(+) DM TYPE 2
(+) GOUT
1999- S/P THYROIDECTOMY SECONDARY TO PAPILLARY CA
DURATION: 4 HOURS
DIALYZER: HIGH FLUX (FDX 180)
ANTICOAGULATION: UNFRACTIONATED HEPARIN (2 ML INITIAL BOLUS, 1 ML HOURLY)
UF GOAL: TO TARGET DRY WEIGHT 72 KG BUT NOT TO EXCEED 1L/HR UF RATE
TELO
PATIENT WAS INITITATED ON CHRONIC HEMODIALYSIS IN OUR FACILITY SINCE JULY 18, 2018. HE IS
JUNE 2014 – CMC ESRD SEC TO URATE/NSAID NEPHROPATHY, INITIATED ON HD STILL WITH GOUTY
FLARES
(+) DM TYPE 2 WIYH NEPHROPATHY, NEUROPATHY & RETINOPATHY
(+) ISHCEMIC/ DILATED CARDIOMYOPATHY
(+)PERIPHERAL ARTERIAL OCCLUSIVE DISEASE WITH DM FOOT GANGRENE
FEBRUARY 2019- BAUTISTA HOSPITAL S/P BKA LEFT, DISARTICULATION 3RD DIGIT LEFT HAND
MARCH 2019- TAKE DOWNOF AVF DUE TO STEAL SYNDROME
DURATION: 4 HOURS
ANTICOAGULATION: UNFRACTIONATED HEPARIN (2 ML INITIAL BOLUS- 0.5 ML HOURLY)
PATIENT HAS DECOMPENSATED CARDIAC RESERVE, HENCE UF RATE IS KEPT LOW TO AVOID
HYPOTENSION AND ARRHTYHMIA
PATIENT WAS DISCHARGED STABLE

CF4FRI

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

CF4FRI

Uploaded by

Copyright:

Available Formats

MACAPAGAL

(+) DM TYPE 2 WITH RETINOPATHY AND NEPHROPATHY

(+) ISCHEMIC CARDIOMYOPATHY

(+) S/POST NSTEMI

STANDING HEMODIALYSIS ORDERS:

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION: LMWHEPARIN 0.3

BLOOD FLOW RATE: 300CC/ML

DIALYSATE FLOW RATE: 700CC/MIN

UF GOAL: TO TARGET DRY WEIGHT OF 86 KG

JANUARY 30, 2014 - CMC; ESRD INITIATED ON HD

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION: UNFRACTIONATED HEPARIN (2ML INITIAL BOLUS, 1ML HOURLY)

BLOOD FLOW RATE: 300 CC/ML

DIALYSATE FLOW RATE: 600 CC/MIN

UF GOAL: TO TARGET DRY WEIGHT BUT NOT TO EXCEED UFR >750CC/HR

NO REPORTABLE INCIDENTS OR COMPLICATIONS OCCURRED DURING THE PROCEDURE.

PATIENT WAS DISCHARGED STABLE.

HE CAME IN FOR HIS REGULAR TREATMENT.

AUGUST 6, 2015 – CMC ESRD SEC TO CHRONIC GLO,ERULONEPHRITIS, INITIATED ON HD

(+) ISCHEMIC CARDIOMYOPATHY WITH RHYTHM DISTURBANCE

(+) COPD BRONCHITIS

STANDING HEMODIALYSIS ORDERS:

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION: LMWH (TINZAPARIN 0.2 ML)

DIALYSATE FLOW RATE: 500CC/MIN

UF GOAL: TO TARGET DRY WEIGHT 65.5 KG

NO REPORTABLE INCIDENTS OR COMPLICATIONS OCCURRED DURING THE PROCEDURE.

(+) DM TYPE 2 W/ NEPHROPATHY AND RETINOPATHY

(+) ISCHEMIC CARDIOMYOPATHY/CHF

S/P BKA BILATERAL

STANDING HEMODIALYSIS ORDERS:

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION:LMWH (TINZAPARIN 0.15 ML)

BLOOD FLOW RATE: 250 CC/ML

DIALYSATE FLOW RATE: 400 CC/MIN

NO REPORTABLE INCIDENTS OR COMPLICATIONS OCCURRED DURING THE PROCEDURE.

PATIENT WAS DISCHARGED STABLE.

(+) BRONCHIAL ASTHMA

STANDING HEMODIALYSIS ORDERS:

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION: UNFRACTIONATED HEPARIN ( 1.5ML INITIAL BOLUS:0.5 ML HOURLY)

BLOOD FLOW RATE: 300CC/ML

DIALYSATE FLOW RATE: 600CC/MIN

UF GOAL: TO TARGET DRY WEIGHT OF 46 KG

SHE WAS DISCHARGED STABLE

(+) AVF FAILURE, 2018

STANDING HEMODIALYSIS ORDERS:

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION: UNFRACTIONATED HEPARIN (2ML INITIAL BOLUS, 0.5- 1ML HOURLY)

BLOOD FLOW RATE: 300CC/ML

DIALYSATE FLOW RATE: 600CC/MIN

UF GOAL: TO TARGET DRY WEIGHT 57 KG

NO REPORTABLE INCIDENTS OR COMPLICATIONS OCCURRED DURING THE PROCEDURE.

PATIENT WAS DISCHARGED STABLE.

JUNE 28, 2013 – CMC ESRD SEC TO DIABETIC KIDNEY DISEASE

STANDING HEMODIALYSIS ORDERS:

DIALYZER: HIGH FLUX (FDH 180)

ANTICOAGULATION: UNFRACTIONATED HEPARIN (2ML INITIAL BOLUS, 1ML HOURLY)

BLOOD FLOW RATE: 300CC/ML

DIALYSATE FLOW RATE: 600CC/MIN

NO REPORTABLE INCIDENTS OR COMPLICATIONS OCCURRED DURING THE PROCEDURE.